The European Parliament Information Office in Marseille, in collaboration with the city of Nice, organized a debate with Michèle Rivasi, Member of the European Parliament. At the Théâtre de la Photographie et de l’image in Nice, the audience of the debate was able to ask questions directly to healthcare professionals.
This debate provided an opportunity for local actors in the medical field, the pharmaceutical industry, laboratories, and user representative associations to meet their European Parliament member and exchange their views on the theme of health.
What is Europe doing to control endocrine disruptors, chemical substances that can interfere with the functioning of our endocrine system and induce harmful effects on our body or that of our descendants?
What about the use of antibiotics to which we are becoming resistant, and how can we address this risk? How can we better understand vaccination? These were some of the questions raised throughout the debate, which Michèle Rivasi took the time to answer.
The European Health Policy
The European health policy is based on the principle that good population health is a condition for achieving European objectives, which are prosperity, solidarity, and security.
The Union’s health strategy pursues three objectives: promoting good health in an aging Europe, protecting citizens from health threats, and advocating for dynamic health systems and new technologies.
The European Parliament, particularly the “Environment, Public Health and Food Safety” committee, has long been involved in establishing a coherent public health policy.
